Nektar Therapeutics | NKTR - Pre Tax Profit

Stock Price
85.07
Daily Change
0.91 1.08%
Monthly
11.58%
Yearly
836.48%
Q2 Forecast
84.66

Nektar Therapeutics reported $-34.7M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
ALKERMES USD 60.38M 40.36M Dec/2025
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Amgen USD 1.51B 2.41B Dec/2025
Baxter International USD -756M 877M Dec/2025
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Cipla INR 11.69B 6.85B Dec/2025
Dr.Reddys Laboratories INR 15.68B 2.38B Dec/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Grifols EUR 257.85M 190.87M Dec/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Incyte USD 343.6M 46.34M Mar/2026
Ionis Pharmaceuticals USD -93M 135M Mar/2026
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Merck USD 3.42B 3.32B Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Neurocrine Biosciences USD 246.8M 7.4M Mar/2026
Novartis USD 3.84B 802M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Roche Holding CHF 4.79B 3.01B Jun/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Xencor USD -4.27M 1.76M Dec/2025